Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 18,664Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 70SUMITOMO PHARMA AM

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

APOMORPHINE HYDROCHLORIDE

US Patent Number : 11419769

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210875

Patent Use Code : U-2825

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-12-16

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

APOMORPHINE HYDROCHLORIDE

US Patent Number : 11419769

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210875

Patent Use Code : U-2825

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-12-16

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

APOMORPHINE HYDROCHLORIDE

US Patent Number : 11419769

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210875

Patent Use Code : U-2825

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-12-16

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

APOMORPHINE HYDROCHLORIDE

US Patent Number : 11419769

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210875

Patent Use Code : U-2825

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-12-16

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

APOMORPHINE HYDROCHLORIDE

US Patent Number : 11419769

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210875

Patent Use Code : U-2825

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-12-16

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

APOMORPHINE HYDROCHLORIDE

US Patent Number : 8414922

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210875

Patent Use Code : U-2825

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-12-16

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

APOMORPHINE HYDROCHLORIDE

US Patent Number : 9669021

Drug Substance Claim :

Drug Product Claim :

Application Number : 210875

Patent Use Code : U-2825

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-06-11

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

APOMORPHINE HYDROCHLORIDE

US Patent Number : 9669019

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210875

Patent Use Code : U-2825

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-06-11

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

APOMORPHINE HYDROCHLORIDE

US Patent Number : 8846074

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210875

Patent Use Code : U-2825

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-12-16

blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

APOMORPHINE HYDROCHLORIDE

US Patent Number : 9283219

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210875

Patent Use Code : U-2825

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-06-11

blank